Abstract |
A new, enantioselective synthesis of the influenza neuraminidase inhibitor prodrug oseltamivir phosphate 1 ( Tamiflu) and its enantiomer ent-1 starting from cheap, commercially available 2,6-dimethoxyphenol 10 is described. The main features of this approach comprise the cis-hydrogenation of 5-(1-ethyl-propoxy)-4,6-dimethoxy-isophthalic acid diethyl ester (6a) and the desymmetrization of the resultant all-cis meso-diesters 7a and 7b, respectively. Enzymatic hydrolysis of the meso-diester 7b with pig liver esterase afforded the (S)-monoacid 8b, which was converted into cyclohexenol 17 via a Curtius degradation and a base-catalyzed decarboxylative elimination of the Boc-protected oxazolidinone 14. Introduction of the second amino function via S(N)2 substitution of the corresponding triflate 18 with NaN3 followed by azide reduction, N-acetylation, and Boc-deprotection gave oseltamivir phosphate 1 in a total of 10 steps and an overall yield of approximately 30%. The enantiomer ent-1 was similarly obtained via an enzymatic desymmetrization of meso-diester 7a with Aspergillus oryzae lipase, providing the (R)-monoacid ent-8a.
|
Authors | Ulrich Zutter, Hans Iding, Paul Spurr, Beat Wirz |
Journal | The Journal of organic chemistry
(J Org Chem)
Vol. 73
Issue 13
Pg. 4895-902
(Jul 04 2008)
ISSN: 1520-6904 [Electronic] United States |
PMID | 18517254
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Dicarboxylic Acids
- Oseltamivir
|
Topics |
- Antiviral Agents
(chemical synthesis)
- Dicarboxylic Acids
(chemistry)
- Molecular Structure
- Oseltamivir
(chemical synthesis)
|